Summary

Early drug development requires manufacturing of Investigational Medicinal Products (IMP) that comply with Good Manufacturing Practice (GMP) systems and processes. PRA Early Development Services (EDS) provides in-house Chemistry, Manufacturing, and Control (CMC) services, including formulation development and real-time manufacture of subject-ready drug products on-site in PRA’s state-of-the-art GMP facilities.

Register to download

Chemical, Manufacturing, and Control Services (CMC)

You may also be interested in: